|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
EP0691864A4
(fr)
*
|
1993-03-03 |
1996-07-03 |
Tenax Corp |
Support de medicament en poudre, pour inhalateur
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
US6182655B1
(en)
|
1995-12-07 |
2001-02-06 |
Jago Research Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(fr)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
HUP0300491A2
(en)
|
2000-02-28 |
2003-07-28 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
CA2477604A1
(fr)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation de la methylation de proteines et du phosphate des phosphoproteines
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
CA2601777A1
(fr)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions et procedes pour l'amelioration de la fonction cognitive
|
|
WO2007052154A2
(fr)
*
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
|
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
US20070049641A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Rabindra Tirouvanziam |
Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315526S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
CA2689296C
(fr)
|
2007-01-10 |
2015-11-17 |
Purdue Research Foundation |
Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
|
|
ES2547229T3
(es)
|
2007-08-07 |
2015-10-02 |
Purdue Research Foundation |
Inhibidores de cinasa y usos de los mismos
|
|
CN101980738A
(zh)
|
2008-02-07 |
2011-02-23 |
华盛顿大学 |
圆周气雾设备
|
|
AU2009248914A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for Treating Neurodegenerative Disorders Related to Neurofibrillary Tangles
|
|
DK2293833T3
(en)
*
|
2008-06-13 |
2016-05-23 |
Mannkind Corp |
DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
|
|
BRPI0919759A2
(pt)
*
|
2008-10-20 |
2017-03-21 |
Moerae Matrix Inc |
polipeptídeos para tratamento e prevenção de adesões
|
|
AU2009313562B2
(en)
*
|
2008-11-04 |
2012-11-15 |
Neurotez, Inc. |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
|
|
US9327008B2
(en)
*
|
2008-12-10 |
2016-05-03 |
Purdue Research Foundation |
Cell-permeant peptide-based inhibitor of kinases
|
|
MX364173B
(es)
|
2009-07-24 |
2019-04-15 |
Amazentis Sa Star |
Compuestos, composiciones y metodos para proteger la salud cerebral en trastornos neurodegenerativos.
|
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
EP4088769A1
(fr)
|
2011-03-03 |
2022-11-16 |
Impel Pharmaceuticals Inc. |
Dispositif d'administration de médicament par voie nasale
|
|
SG10201604560TA
(en)
|
2011-04-12 |
2016-07-28 |
Moerae Matrix Inc |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
WO2012148998A1
(fr)
|
2011-04-25 |
2012-11-01 |
Cornell University |
Utilisation d'uridine et de désoxyuridine pour traiter les pathologies répondant aux folates
|
|
AU2012253569B2
(en)
|
2011-05-09 |
2018-02-15 |
Impel Pharmaceuticals Inc. |
Nozzles for nasal drug delivery
|
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
|
WO2013134636A1
(fr)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions et procédés d'administration de peptides inhibiteurs de kinases
|
|
JP2015530387A
(ja)
|
2012-09-04 |
2015-10-15 |
エライゾン ファーマシューティカルズ， エルエルシー |
脂質複合体化シスプラチンによる肺癌の再発防止
|
|
CA2909954C
(fr)
|
2013-04-28 |
2021-03-23 |
Impel Neuropharma, Inc. |
Flacon a dose unitaire medical
|
|
US10207065B2
(en)
|
2013-07-12 |
2019-02-19 |
John H. Silva |
Mouthpiece for inhalers
|
|
RU2727516C2
(ru)
|
2013-09-10 |
2020-07-22 |
Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Терапевтические средства, нацеленные на укороченные белки аденоматозного полипоза толстого кишечника (арс)
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
RU2017121090A
(ru)
|
2014-11-17 |
2018-12-20 |
Мори Матрикс, Инк. |
Композиции и способы для профилактики или лечения заболеваний, состояний или процессов, характеризующихся аберрантной пролиферацией фибробластов и накоплением внеклеточного матрикса
|
|
AU2015359043C1
(en)
|
2014-12-10 |
2022-01-06 |
Hyperstem, SA |
Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brian tumors
|
|
HK1246807A1
(zh)
|
2015-01-08 |
2018-09-14 |
Moerae Matrix, Inc. |
Mk2抑制剂肽的制剂
|
|
KR20170125090A
(ko)
|
2015-03-12 |
2017-11-13 |
모레 매트릭스 인코포레이티드 |
비-세포 폐암을 치료하기 위한 mk2 저해제 펩타이드-함유 조성물의 용도
|
|
WO2016200694A1
(fr)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Utilisation du telmisartan pour la prévention et le traitement de la maladie du greffon contre l'hôte et d'autres maladies auto-immunes et allo-immunes
|
|
CN107949279A
(zh)
|
2015-07-06 |
2018-04-20 |
得克萨斯系统大学评议会 |
可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
|
|
WO2017011215A1
(fr)
|
2015-07-15 |
2017-01-19 |
The Board Of Regents Of The University Of Texas System |
Ciblage de protéine de liaison de l'emopamil (ebp) avec de petites molécules qui induisent une réponse de rétroaction anormale par l'abaissement de la biosynthèse du cholestérol endogène
|
|
EP3341059B1
(fr)
|
2015-09-10 |
2022-03-02 |
Impel NeuroPharma Inc. |
Dispositif d'administration nasale en ligne
|
|
EP3405175A4
(fr)
|
2016-01-20 |
2019-09-25 |
Flurry Powders, LLC |
Encapsulation d'ingrédients lipophiles dans des poudres séchées par pulvérisation pouvant être dispersées destinées à l'inhalation
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
US11571532B2
(en)
|
2017-11-21 |
2023-02-07 |
Impel Pharmaceuticals Inc. |
Intranasal device with dip tube
|
|
EP3713626A4
(fr)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
Dispositif intra-nasale avec interface d'entrée
|
|
BR112020013750A8
(pt)
|
2018-01-05 |
2022-10-18 |
Impel Neuropharma Inc |
Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
|
|
JP7317020B2
(ja)
|
2018-01-05 |
2023-07-28 |
インペル ファーマシューティカルズ インコーポレイテッド |
精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
|
|
CN112955134A
(zh)
|
2018-07-19 |
2021-06-11 |
英倍尔药业股份有限公司 |
用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
|
|
EA202191856A1
(ru)
|
2019-01-03 |
2021-09-02 |
Импел Ньюрофарма, Инк. |
Устройство для назальной доставки лекарственных средств
|
|
US11878109B2
(en)
|
2019-05-17 |
2024-01-23 |
Impel Pharmaceuticals Inc. |
Single-use nasal delivery device
|